autoantibody
[대역어] 자가항체
[용어속성] Term
[용어속성] Term
Acquired Thrombotic Thrombocytopenic Purpura After BNT162b2 COVID-19 Vaccine: Case Report and Literature Review
Article
[키워드] Acquired
ADAMTS
Anemia
autoantibody
Blood
BNT162b2
BNT162b2 vaccine
caplacizumab
caused
Complete
COVID-19
COVID-19 vaccine
deficiency
Diagnosis
gastrointestinal symptoms
immunosuppressive
literature
microangiopathy
MOST
occurred
outcome
Patient
patients
Pfizer-BioNTech
plasma
positive
Prednisone
presenting
report
reported
review
second dose
significantly
the patient
therapy
thrombocytopenia
thrombosis
thrombotic
Thrombotic thrombocytopenic purpura
treated
Treatment
Vaccine
vaccine.
was used
[DOI] 10.1093/labmed/lmac016 PMC 바로가기
[DOI] 10.1093/labmed/lmac016 PMC 바로가기
Genetic and immunologic evaluation of children with inborn errors of immunity and severe or critical COVID-19
Article
[키워드] acute respiratory syndrome
Affect
antibodies
Asymptomatic
autoantibody
B-cell function
children
children with COVID-19
complement
Complication
complications
coronavirus
coronavirus disease
COVID-19
COVID-19 complications
COVID-19 disease
Critical
detectable
develop
diagnosed
Diagnostic Criteria
died
disease
evaluated
Genetic
genetic cause
genetic diagnosis
help
hypoxemic
IFN signaling
IFN-I
immune
immune response
Immunity
immunodeficiency
Inborn error
inborn errors of immunity
individual
infected with SARS-CoV-2
Infection
Inflammasome
Inflammatory
Inflammatory factor
Mild
Molecular diagnosis
Mortality
mortality rate
MOST
multisystem inflammatory syndrome in children (MIS-C)
Mutation
Neutralizing
Patient
patients
patients with asymptomatic
Pediatric patients
plasma
Pneumonia
primary immunodeficiency.
reported
SARS-CoV-2
SARS-CoV-2-specific antibodies
severe COVID-19 disease
syndrome
tested
Treatment
Type I IFN
was performed
were measured
whole-exome sequencing
[DOI] 10.1016/j.jaci.2022.09.005 PMC 바로가기
[DOI] 10.1016/j.jaci.2022.09.005 PMC 바로가기
New-onset dermatomyositis following COVID-19: A case report
Article
[키워드] acute respiratory syndrome
addition
anti-aminoacyl tRNA synthetase (ARS) antibodies
anti-synthetase antibodies
antibodies
antibody
association
autoantibody
Autoimmune
Autoimmune disease
Autoimmune diseases
biochemical analysis
Biological
Case report
caused
Chest
clinical feature
Clinical features
complications
Computed tomography
contributed
coronavirus
Coronavirus disease 2019
Corticosteroids
cough
COVID-19
de novo
dermatomyositis
dermatomyositis.
develop
diagnosed
diagnostic
Dyspnea
edema
elevations
enzyme-linked immunosorbent
exacerbate
Fever
highlight
Hospitalization
IgG
ILD
immunoblot
infected individual
Infectious disease
Inflammatory
interstitial
Interstitial lung disease
Japan
Japanese
lower lobe
Lungs
male
manifestation
MOST
myalgia
myopathies
myositis
Occurrence
organ
pathological findings
Patient
polymerase chain
positive
Prednisolone
presenting
profile
respiratory symptom
SARS-CoV-2
skin rash
sore throat
Swab
syndrome
tested
transaminases
treated
tRNA
weakness
[DOI] 10.3389/fimmu.2022.1002329 PMC 바로가기
[DOI] 10.3389/fimmu.2022.1002329 PMC 바로가기
Delayed encephalopathy after COVID-19: A case series of six patients
Article
[키워드] absence
accompanied
acute respiratory syndrome
Administered
age
autoantibody
case sery
cerebrospinal fluid
characterized
Computed tomography
contribute
coronavirus
coronavirus disease
COVID-19
CSF
Delayed
demonstrated
disturbance of consciousness
Duration
dysfunction
electroencephalogram
elevated
Encephalopathy
evaluated
female
Hospitalization
Immunoglobulin
Immunotherapy
interleukin-6
lacunar infarction
magnetic resonance imaging
males
moderate
MOST
neurological
Neurological deficit
occur
Pathogenesis
Patient
patients
polymerase chain
protein level
pulse
ranged
remained
Repeat
resolved
reverse transcription
serum
severity of COVID-19
Symptom
Treatment
with COVID-19
worsening
[DOI] 10.1097/MD.0000000000031029 PMC 바로가기
[DOI] 10.1097/MD.0000000000031029 PMC 바로가기
Inflammatory myopathy following coronavirus disease 2019 vaccination: A systematic review
Article
[키워드] accompanied
adverse event
antibodies
article
autoantibodies
autoantibody
BNT162b2
ChAdOx1
Clinical course
clinical feature
complications
composed
conducted
coronavirus disease
coronavirus disease 2019 vaccine
COVID-19
COVID-19 vaccination
COVID-19 vaccine
critical appraisal
dermatomyositis
Follow-up
identify
Immune-mediated
IMPROVE
independent
induce
Inflammatory
inflammatory myopathy
investigator
Joanna Briggs Institute
management
muscular
myositis
myositis specific autoantibodies.
occurred
Onset
Patient
patients
presenting
proportion
report
reported
Risk of bias
SARS-CoV-2
SARS-CoV-2 vaccine
searched
Side effect
skin rash
Specific
subtype
Symptom
systematic review
Treatment
vaccination
Vaccine
vaccine dose
weakness
were used
[DOI] 10.3389/fpubh.2022.1007637 PMC 바로가기
[DOI] 10.3389/fpubh.2022.1007637 PMC 바로가기
Autoantibodies – enemies, and/or potential allies?
Article
[키워드] antibody
Antigen
autoantibodies
autoantibody
Autoimmune
Autoimmune disease
Autoimmune diseases
binding
Biomarker
Cancer
caused
COVID
COVID - 19
COVID-19
Diagnosis
diagnostics
disease
Disease diagnosis
disease-associated
global pandemic
Host
include
positive
predict
Prognosis
self-antigens
stability
Symptom
therapy
Treatment
Treatment.
[DOI] 10.3389/fimmu.2022.953726 PMC 바로가기
[DOI] 10.3389/fimmu.2022.953726 PMC 바로가기
Lipidomics Revealed Plasma Phospholipid Profile Differences between Deceased and Recovered COVID-19 Patients
Article
[키워드] abnormality
addition
analyzed
Anemia
appear
autoantibody
changes
characterized
control group
coronavirus
COVID-19
COVID-19 patients
CRP level
Deceased
decrease
difference
disorder
disorders
FIVE
healthy
immune system
increase in
Increased
LDH
Lipidomics
Liver damage
low-density
Low-density lipoprotein
majority
Modification
oxidative
oxidative stress
pathophysiological
Patient
patients
Phosphatidylcholine
Phosphatidylserine
phospholipid
Phospholipids
plasma
plasma.
profile
profiles
Prognostic value
recovered
recovered patient
recovered patients
reported
Revealed
SARS-CoV-2
significantly
two subgroup
[DOI] 10.3390/biom12101488 PMC 바로가기
[DOI] 10.3390/biom12101488 PMC 바로가기
TIMELESS is a key gene mediating thrombogenesis in COVID-19 and antiphospholipid syndrome
Article
[키워드] Analysis
analysis
antibody
autoantibody
autophagy gene
Bioinformatics analysis
Cell
circadian clock
Coagulation
contribute
COVID-19
COVID-19 patient
COVID-19 patients
Critically ill
cytoHubba
Cytoscape software
dataset
Differentially expressed genes
evaluated
expression
Genes
Genetic
GSK3B
identify
Immune-mediated
Immunotherapy
increased risk
Interference
investigated
Kyoto
mechanism
Mild
Modification
mononuclear cell
ontology term
pathway
Patient
patients
protein-protein interaction
Proteins
regulate
severe COVID-19
severe COVID-19 patient
severe COVID-19 patients
severity
suggested
Symptom
syndrome
therapeutic potential
thrombosis
Transcriptome
were used
with COVID-19
[DOI] 10.1038/s41598-022-21694-3 PMC 바로가기
[DOI] 10.1038/s41598-022-21694-3 PMC 바로가기
Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity
Article
[키워드] ACE2
acute respiratory syndrome
angiotensin-converting enzyme 2
antibody
autoantibody
Blood
blood pressure
coronavirus
COVID-19
develop
disease severity
distress
domain
dysregulation
epitope
hospitalized patient
immune reaction
impair
induce
life-threatening
main entry receptor
Oxygenation
peptide
proportion
Protein
RBD
regulate
Regulation
SARS-CoV-2
spike
the SARS-CoV-2
thought
thrombosis
with COVID-19
[DOI] 10.1126/sciadv.abn3777 PMC 바로가기
[DOI] 10.1126/sciadv.abn3777 PMC 바로가기